• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New cardiovascular risk factors and their use for an accurate cardiovascular risk assessment in hypertensive patients.新的心血管危险因素及其在高血压患者准确心血管风险评估中的应用。
Maedica (Bucur). 2014 Jun;9(2):127-34.
2
Visit-to-Visit Blood Pressure Variability and Arterial Stiffness Independently Predict Cardiovascular Risk Category in a General Population: Results from the SEPHAR II Study.动态血压变异性和动脉僵硬度独立预测普通人群心血管风险类别:来自 SEPHAR II 研究的结果。
Hellenic J Cardiol. 2015 May-Jun;56(3):208-16.
3
Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects.在血压正常且从未接受过治疗的高血压患者中,血浆致动脉粥样硬化指数与动脉僵硬度有关,而与血压无关。
Blood Press. 2019 Jun;28(3):157-167. doi: 10.1080/08037051.2019.1583060. Epub 2019 Mar 1.
4
Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients.收缩压的随访间变异性:与经治疗的高血压患者动脉僵硬度和心肌灌注变化相关。
Clin Exp Hypertens. 2015;37(1):63-9. doi: 10.3109/10641963.2014.897724. Epub 2014 Mar 28.
5
Significance of arterial stiffness and relationship with other noninvasive methods for the assessment of subclinical atherosclerosis inpatients with metabolic syndrome.动脉僵硬度的意义及其与评估代谢综合征患者亚临床动脉粥样硬化的其他非侵入性方法的关系。
Rev Med Chir Soc Med Nat Iasi. 2013 Jan-Mar;117(1):59-64.
6
Serum uric acid and arterial hypertension-Data from Sephar III survey.血清尿酸与动脉高血压——Sephar III 调查数据。
PLoS One. 2018 Jul 2;13(7):e0199865. doi: 10.1371/journal.pone.0199865. eCollection 2018.
7
8
High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects.高血清尿酸与高血压患者血压控制不佳及较高的动脉僵硬度有关。
Eur J Intern Med. 2017 Jan;37:38-42. doi: 10.1016/j.ejim.2016.07.026. Epub 2016 Aug 3.
9
Profile of the Romanian hypertensive patient data from SEPHAR II study.来自SEPHAR II研究的罗马尼亚高血压患者数据概况。
Rom J Intern Med. 2012 Oct-Dec;50(4):285-96.
10
Ambulatory Arterial Stiffness Index (AASI) is Unable to Estimate Arterial Stiffness of Hypertensive Subjects: Role of Nocturnal Dipping of Blood Pressure.动态动脉僵硬度指数(AASI)无法评估高血压患者的动脉僵硬度:夜间血压波动的作用
Curr Hypertens Rev. 2017;13(2):121-131. doi: 10.2174/1573402113666170621110305.

引用本文的文献

1
Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia.家族性高胆固醇血症患者心血管风险预测指标与超重及肥胖的相关性
Front Cardiovasc Med. 2022 Nov 28;9:1026243. doi: 10.3389/fcvm.2022.1026243. eCollection 2022.
2
Noninvasive Blood Pressure Measurement Using the NICCI Monitor in Adolescents During Intraoperative Anesthetic Care.在青少年术中麻醉护理期间使用NICCI监护仪进行无创血压测量。
Cardiol Res. 2022 Jun;13(3):154-161. doi: 10.14740/cr1378. Epub 2022 Jun 2.
3
Investigation of the accuracy of a noninvasive continuous blood pressure device in different age groups and its ability in detecting hypertension and hypotension: an observational study.探讨一种非侵入性连续血压设备在不同年龄组中的准确性及其检测高血压和低血压的能力:一项观察性研究。
BMC Anesthesiol. 2019 Dec 5;19(1):223. doi: 10.1186/s12871-019-0899-z.
4
Atherosclerosis risk assessment in patients with chronic obstructive pulmonary disease: a case-control study.慢性阻塞性肺疾病患者的动脉粥样硬化风险评估:一项病例对照研究。
Ther Clin Risk Manag. 2019 Aug 29;15:1061-1071. doi: 10.2147/TCRM.S216180. eCollection 2019.
5
CARDIOVASCULAR RISK ASSESSMENT IN THE ADULT (AGED 40-79 YEARS) ROMANIAN POPULATION.罗马尼亚成年人群(40 - 79岁)的心血管风险评估
Acta Endocrinol (Buchar). 2018 Apr-Jun;14(2):227-234. doi: 10.4183/aeb.2018.227.

本文引用的文献

1
Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys.罗马尼亚高血压患病率和控制率的七年变化。SEPHAR I 和 II 调查的比较。
J Hypertens. 2014 Jan;32(1):39-47. doi: 10.1097/01.hjh.0000434937.62412.24.
2
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
3
Profile of the Romanian hypertensive patient data from SEPHAR II study.来自SEPHAR II研究的罗马尼亚高血压患者数据概况。
Rom J Intern Med. 2012 Oct-Dec;50(4):285-96.
4
Serum uric acid: marker for atherosclerosis as it is positively associated with "atherogenic index of plasma".血清尿酸:作为动脉粥样硬化的标志物,因为它与“血浆致动脉粥样硬化指数”呈正相关。
Arch Physiol Biochem. 2013 Feb;119(1):27-31. doi: 10.3109/13813455.2012.732580. Epub 2012 Oct 19.
5
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.使用 SCORE、Framingham 和 ESH/ESC 风险图表的脉搏波速度、尿白蛋白肌酐比和左心室质量指数的阈值。
J Hypertens. 2012 Oct;30(10):1928-36. doi: 10.1097/HJH.0b013e328356c579.
6
High plasma uric acid concentration: causes and consequences.高血浆尿酸浓度:原因与后果。
Diabetol Metab Syndr. 2012 Apr 4;4:12. doi: 10.1186/1758-5996-4-12.
7
The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994.在一般人群中,收缩压的访间变异性与全因死亡率之间的关系:来自 NHANES III 的研究结果,1988 年至 1994 年。
Hypertension. 2011 Feb;57(2):160-6. doi: 10.1161/HYPERTENSIONAHA.110.162255. Epub 2011 Jan 3.
8
Aortic stiffness: prime time for integration into clinical practice?
Hellenic J Cardiol. 2010 Sep-Oct;51(5):385-90.
9
Evaluating aortic stiffness through an arm cuff oscillometric device: is validation against invasive measurements enough?通过手臂袖带示波装置评估主动脉僵硬度:与侵入性测量方法进行验证是否足够?
J Hypertens. 2010 Oct;28(10):2003-6. doi: 10.1097/HJH.0b013e32833f0e93.
10
Obtaining arterial stiffness indices from simple arm cuff measurements: the holy grail?
J Hypertens. 2009 Nov;27(11):2159-61. doi: 10.1097/HJH.0b013e328332f588.

新的心血管危险因素及其在高血压患者准确心血管风险评估中的应用。

New cardiovascular risk factors and their use for an accurate cardiovascular risk assessment in hypertensive patients.

作者信息

Tautu Oana-Florentina, Darabont Roxana, Onciul Sebastian, Deaconu Alexandru, Comanescu Ioana, Andrei Radu Dan, Dragoescu Bogdan, Cinteza Mircea, Dorobantu Maria

机构信息

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Department of Cardiology, Clinical Emergency Hospital Bucharest, Romania.

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Department of Cardiology, Emergency University Hospital, Bucharest, Romania.

出版信息

Maedica (Bucur). 2014 Jun;9(2):127-34.

PMID:25705267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4296754/
Abstract

OBJECTIVES

To analyze the predictive value of new cardiovascular (CV) risk factors for CV risk assessment in the adult Romanian hypertensive (HT) population.

METHODS

Hypertensive adults aged between 40-65 years of age, identified in national representative SEPHAR II survey were evaluated by anthropometric, BP and arterial stiffness measurements: aortic pulse wave velocity (PWVao), aortic augmentation index (AIXao), revers time (RT) and central systolic blood pressure (SBPao), 12 lead ECGs and laboratory workup. Values above the 4th quartile of mean SBP' standard deviation (s.d.) defined increased BP variability. Log(TG/HDL-cholesterol) defined atherogenic index of plasma (AIP). Serum uric acid levels above 5.70 mg/dl for women and 7.0 mg/dl for males defined hyperuricemia (HUA). CV risk was assessed based on SCORE chart for high CV risk countries. Binary logistic regression using a stepwise likelihood ratio method (adjustments for major confounders and colliniarity analysis) was used in order to validate predictors of high and very high CV risk class.

RESULTS

The mean SBP value of the study group was 148.46±19.61 mmHg. Over forty percent of hypertensives had a high and very high CV risk. Predictors of high/very high CV risk category validated by regression analysis were: increased visit-to-visit BP variability (OR: 2.49; 95%CI: 1.67-3.73), PWVao (OR: 1.12; 95%CI: 1.02-1.22), RT (OR: 0.95; 95% CI: 0.93-0.98), SBPao (OR: 1.01; 95%CI: 1.01-1.03) and AIP (OR: 7.08; 95%CI: 3.91-12.82).

CONCLUSION

The results of our study suggests that the new CV risk factors such as increased BP variability, arterial stiffness indices and AIP are useful tools for a more accurate identification of hypertensives patients at high and very high CV risk.

摘要

目的

分析新的心血管(CV)危险因素对罗马尼亚成年高血压(HT)人群CV风险评估的预测价值。

方法

在具有全国代表性的SEPHAR II调查中确定的40 - 65岁成年高血压患者,通过人体测量、血压和动脉僵硬度测量进行评估:主动脉脉搏波速度(PWVao)、主动脉增强指数(AIXao)、反向时间(RT)和中心收缩压(SBPao)、12导联心电图和实验室检查。平均收缩压标准差(s.d.)高于第4四分位数的值定义为血压变异性增加。Log(甘油三酯/高密度脂蛋白胆固醇)定义为血浆致动脉粥样硬化指数(AIP)。女性血清尿酸水平高于5.70 mg/dl,男性高于7.0 mg/dl定义为高尿酸血症(HUA)。基于高CV风险国家的SCORE图表评估CV风险。使用逐步似然比方法(对主要混杂因素进行调整和共线性分析)的二元逻辑回归用于验证高和非常高CV风险类别的预测因素。

结果

研究组的平均收缩压值为148.46±19.61 mmHg。超过40%的高血压患者具有高和非常高的CV风险。通过回归分析验证的高/非常高CV风险类别的预测因素为:就诊间血压变异性增加(OR:2.49;95%CI:1.67 - 3.73)、PWVao(OR:1.12;95%CI:1.02 - 1.22)、RT(OR:0.95;95%CI:0.93 - 0.98)、SBPao(OR:1.01;95%CI:1.01 - 1.03)和AIP(OR:7.08;95%CI:3.91 - 12.82)。

结论

我们的研究结果表明,新的CV危险因素,如血压变异性增加、动脉僵硬度指数和AIP,是更准确识别高和非常高CV风险高血压患者的有用工具。